| Net Cash Provided by (Used in) Operating Activities |
$9,265,000 |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$23,137,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$138,000 |
USD |
97% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$12,307,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$27,002,000 |
USD |
14% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$869,000 |
USD |
-8.8% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$14,934,000 |
USD |
35% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Gross |
$26,192,000 |
USD |
11% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability |
$290,000 |
USD |
-68% |
Q2 2025 |
Q2 2025 |
| Depreciation |
$1,272,000 |
USD |
15% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$17,000 |
USD |
-90% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$4,936,000 |
USD |
-54% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$294,000 |
USD |
-69% |
Q2 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$47,345,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
$258,000 |
USD |
-66% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$10,000 |
USD |
-33% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$66,000 |
USD |
-88% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q2 2025 |
Q2 2025 |
| Deferred Income Tax Expense (Benefit) |
$142,000 |
USD |
54% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$4,000 |
USD |
-84% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$11,707,000 |
USD |
13% |
Q2 2025 |
Q2 2025 |
| Current Income Tax Expense (Benefit) |
$58,000 |
USD |
-49% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$14,934,000 |
USD |
35% |
Q2 2025 |
Q2 2025 |
| Share-based Payment Arrangement, Expense |
$370,000 |
USD |
-1.1% |
Q1 2025 |
Q1 2025 |